ALLICIA VENTRESCA: Open Payments
NPI 1912764085 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 83 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $786 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $278 |
| Merck Sharp & Dohme LLC | 11 | $218 |
| PFIZER INC. | 12 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| Myriad Genetic Laboratories, Inc. | 1 | $105 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Incyte Corporation | 3 | $62 |
Products named: KEYTRUDA, DARZALEX, MYRISK, LIBTAYO, XYNTHA, Nubeqa, ERLEADA, Vyloy.
Industry payments across MO — which companies pay providers there.
